Threshold Pharmaceuticals Inc.
1300 Seaport Boulevard
Suite 500
Redwood City,
CA 94063
United States - Map
Phone: 650-474-8200
Fax: 650-474-2529
Web Site: http://www.thresholdpharm.com
| Threshold Pharmaceuticals, Inc., a biotechnology company, engages in the discovery and development of drugs targeting the microenvironment of solid tumors for patients living with cancer. Its product line includes TH-302, a product candidate in phase I/II for the potential treatment of patients with cancer; Glufosfamide for the treatment of pancreatic cancer; and 2DG, a phase I product candidate for the treatment of patients with cancer. The company was founded in 2001 and is headquartered in Redwood City, California. |
|
| Key Statistics |
| |
| | Pay | Exercised | Dr. Harold E. Selick Ph.D., 53
Exec. Chairman and Chief Exec. Officer |
$
550.00K |
$
16.02M | Dr. John G. Curd M.D., 63
Pres and Chief Medical Officer |
$
400.00K | N/A | Dr. Mark D. Matteucci Ph.D., 55
Sr. VP of Discovery Research |
$
305.00K | N/A | Dr. George Tidmarsh M.D., Ph.D., 49
Founder, Chairman of the Clinical Advisory Board and Consultant |
N/A
| N/A | Mr. Joel A. Fernandes , 39
Principal Financial Officer, Principal Accounting Officer, Sr. Director of Fin. and Controller |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
1.48% Nasdaq 
0.01 (0.51%) 
Profile
